Cargando…

An extended dose–volume model in high dose‐rate brachytherapy – Using mean‐tail‐dose to reduce tumor underdosage

PURPOSE: High dose–rate brachytherapy is a method of radiotherapy for cancer treatment in which the radiation source is placed within the body. In addition to give a high enough dose to a tumor, it is also important to spare nearby healthy organs [organs at risk (OAR)]. Dose plans are commonly evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Morén, Björn, Larsson, Torbjörn, Carlsson Tedgren, Åsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852298/
https://www.ncbi.nlm.nih.gov/pubmed/30972758
http://dx.doi.org/10.1002/mp.13533
_version_ 1783469801487728640
author Morén, Björn
Larsson, Torbjörn
Carlsson Tedgren, Åsa
author_facet Morén, Björn
Larsson, Torbjörn
Carlsson Tedgren, Åsa
author_sort Morén, Björn
collection PubMed
description PURPOSE: High dose–rate brachytherapy is a method of radiotherapy for cancer treatment in which the radiation source is placed within the body. In addition to give a high enough dose to a tumor, it is also important to spare nearby healthy organs [organs at risk (OAR)]. Dose plans are commonly evaluated using the so‐called dosimetric indices; for the tumor, the portion of the structure that receives a sufficiently high dose is calculated, while for OAR it is instead the portion of the structure that receives a sufficiently low dose that is of interest. Models that include dosimetric indices are referred to as dose–volume models (DVMs) and have received much interest recently. Such models do not take the dose to the coldest (least irradiated) volume of the tumor into account, which is a distinct weakness since research indicates that the treatment effect can be largely impaired by tumor underdosage even to small volumes. Therefore, our aim is to extend a DVM to also consider the dose to the coldest volume. METHODS: An improved DVM for dose planning is proposed. In addition to optimizing with respect to dosimetric indices, this model also takes mean dose to the coldest volume of the tumor into account. RESULTS: Our extended model has been evaluated against a standard DVM in ten prostate geometries. Our results show that the dose to the coldest volume could be increased, while also computing times for the dose planning were improved. CONCLUSION: While the proposed model yields dose plans similar to other models in most aspects, it fulfils its purpose of increasing the dose to cold tumor volumes. An additional benefit is shorter solution times, and especially for clinically relevant times (of minutes) we show major improvements in tumour dosimetric indices.
format Online
Article
Text
id pubmed-6852298
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68522982019-11-22 An extended dose–volume model in high dose‐rate brachytherapy – Using mean‐tail‐dose to reduce tumor underdosage Morén, Björn Larsson, Torbjörn Carlsson Tedgren, Åsa Med Phys THERAPEUTIC INTERVENTIONS PURPOSE: High dose–rate brachytherapy is a method of radiotherapy for cancer treatment in which the radiation source is placed within the body. In addition to give a high enough dose to a tumor, it is also important to spare nearby healthy organs [organs at risk (OAR)]. Dose plans are commonly evaluated using the so‐called dosimetric indices; for the tumor, the portion of the structure that receives a sufficiently high dose is calculated, while for OAR it is instead the portion of the structure that receives a sufficiently low dose that is of interest. Models that include dosimetric indices are referred to as dose–volume models (DVMs) and have received much interest recently. Such models do not take the dose to the coldest (least irradiated) volume of the tumor into account, which is a distinct weakness since research indicates that the treatment effect can be largely impaired by tumor underdosage even to small volumes. Therefore, our aim is to extend a DVM to also consider the dose to the coldest volume. METHODS: An improved DVM for dose planning is proposed. In addition to optimizing with respect to dosimetric indices, this model also takes mean dose to the coldest volume of the tumor into account. RESULTS: Our extended model has been evaluated against a standard DVM in ten prostate geometries. Our results show that the dose to the coldest volume could be increased, while also computing times for the dose planning were improved. CONCLUSION: While the proposed model yields dose plans similar to other models in most aspects, it fulfils its purpose of increasing the dose to cold tumor volumes. An additional benefit is shorter solution times, and especially for clinically relevant times (of minutes) we show major improvements in tumour dosimetric indices. John Wiley and Sons Inc. 2019-05-15 2019-06 /pmc/articles/PMC6852298/ /pubmed/30972758 http://dx.doi.org/10.1002/mp.13533 Text en © 2019 The Authors. Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle THERAPEUTIC INTERVENTIONS
Morén, Björn
Larsson, Torbjörn
Carlsson Tedgren, Åsa
An extended dose–volume model in high dose‐rate brachytherapy – Using mean‐tail‐dose to reduce tumor underdosage
title An extended dose–volume model in high dose‐rate brachytherapy – Using mean‐tail‐dose to reduce tumor underdosage
title_full An extended dose–volume model in high dose‐rate brachytherapy – Using mean‐tail‐dose to reduce tumor underdosage
title_fullStr An extended dose–volume model in high dose‐rate brachytherapy – Using mean‐tail‐dose to reduce tumor underdosage
title_full_unstemmed An extended dose–volume model in high dose‐rate brachytherapy – Using mean‐tail‐dose to reduce tumor underdosage
title_short An extended dose–volume model in high dose‐rate brachytherapy – Using mean‐tail‐dose to reduce tumor underdosage
title_sort extended dose–volume model in high dose‐rate brachytherapy – using mean‐tail‐dose to reduce tumor underdosage
topic THERAPEUTIC INTERVENTIONS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852298/
https://www.ncbi.nlm.nih.gov/pubmed/30972758
http://dx.doi.org/10.1002/mp.13533
work_keys_str_mv AT morenbjorn anextendeddosevolumemodelinhighdoseratebrachytherapyusingmeantaildosetoreducetumorunderdosage
AT larssontorbjorn anextendeddosevolumemodelinhighdoseratebrachytherapyusingmeantaildosetoreducetumorunderdosage
AT carlssontedgrenasa anextendeddosevolumemodelinhighdoseratebrachytherapyusingmeantaildosetoreducetumorunderdosage
AT morenbjorn extendeddosevolumemodelinhighdoseratebrachytherapyusingmeantaildosetoreducetumorunderdosage
AT larssontorbjorn extendeddosevolumemodelinhighdoseratebrachytherapyusingmeantaildosetoreducetumorunderdosage
AT carlssontedgrenasa extendeddosevolumemodelinhighdoseratebrachytherapyusingmeantaildosetoreducetumorunderdosage